Crowe & Dunlevy Company Profile

18:34 EST 18th November 2017 | BioPortfolio

News Articles [5 Associated News Articles listed on BioPortfolio]

Pfizer Completes License Agreement For The Exclusive Commercialization Rights In Europe For ...

Pfizer Inc.Media:Rachel Hooper, 916-708-1868orInvestorsRyan Crowe, 212-733-8160

U.S. FDA and European Medicines Agency Accept Regulatory Submissions for BOSULIF® (bosutinib) for the Treatment of Patients with Newly Diagnosed Ph+ Chronic Myeloid Leukemia

Dateline City: LONDON & NEW YORK Applications seek to expand approved use of BOSULIF into ...

Novo Nordisk Extends Commitment to World’s First All-Diabetes Professional Cycling Team Through 2019

Danish pharmaceutical company Novo Nordisk renewed its partnership with Team Novo Nordisk, the world's first all-diabetes pro cycling team, for two more years as they continue to work together to ...

Lilly Announces Senior Leadership Appointments for Finance, Research & Development and Manufacturing

INDIANAPOLIS, Sept. 29, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced a number of leadership changes, promoting several experienced Lilly leaders to executive roles, effective...

UK Triathlon Standout Moves Up to Team Novo Nordisk Pro Squad as Stagiaire

Team Novo Nordisk announced Thursday that former triathlete Sam Brand will race for the men's professional team for the remainder of the 2017 season. Brand, who was diagnosed with type 1 diabetes ...

Drugs and Medications [0 Results]


PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Total hip arthroplasty for patients with Crowe type IV developmental dysplasia of the hip: ten years results.

The aim of this study was to determine the rate of union, functional results and complications in patients with Crowe IV developmental dysplasia of the hip (DDH) who underwent cementless total hip art...

Morphological Analysis of True Acetabulum in Hip Dysplasia (Crowe Classes I-IV) Via 3-D Implantation Simulation.

The purpose of this study was to investigate the 3-dimensional (3D) morphological features of the true acetabulum in patients with developmental dysplasia of the hip (DDH).

Does restoration of hip center with subtrochanteric osteotomy provide preferable outcome for Crowe type III-IV irreducible development dysplasia of the hip??

Subtrochanteric osteotomy and proximal placement of acetabular components are two common procedures used to manage irreducible, high riding developmental dysplasia of the hip (DDH). Some common and sp...

The Relationship Between Subluxation Percentage of the Femoroacetabular Joint and Acetabular Width in Asian Women with Developmental Dysplasia of the Hip.

Implantation of the acetabular cup insert in the "true" location of the acetabulum is a fundamental principle of total hip arthroplasty for the treatment of secondary osteoarthritis due to development...

Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]

Crowe Horwath LLP

Crowe Horwath LLP ( is one of the largest public accounting and consulting firms in the United States. Under its core purpose of "Building Value with Values®," Crowe assists publ...

Crowe Paradis Services Corporation

Crowe Paradis Services Corporation (“CPSC”) is a results-driven Medicare compliance firm addressing the broad spectrum of legal and clinical issues facing insurance comp...

More Information about "Crowe & Dunlevy" on BioPortfolio

We have published hundreds of Crowe & Dunlevy news stories on BioPortfolio along with dozens of Crowe & Dunlevy Clinical Trials and PubMed Articles about Crowe & Dunlevy for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Crowe & Dunlevy Companies in our database. You can also find out about relevant Crowe & Dunlevy Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record